| diabetes | no-diabetes | P | logistics |
n | 199 | 375 |
|
|
Age, median [Q1, Q3] | 59.00 [47.50, 66.50] | 52.00 [41.00, 64.00] | <0.001* | 0.006 |
Male, n | 140 | 212 | 0.001 | 0.007 |
Male, (%) | 70.35% | 56.53% | ||
ethnicity |
|
|
|
|
white, n | 115 | 230 |
|
|
white, (%) | 57.79% | 61.33% |
|
|
BLACK/AFRICAN AMERICAN, n | 32 | 37 |
|
|
BLACK/AFRICAN AMERICAN, (%) | 16.08% | 9.87% |
|
|
AMERICAN INDIAN/ALASKA NATIVE, n | 2 | 0 |
|
|
AMERICAN INDIAN/ALASKA NATIVE, (%) | 1.01% | 0.00% |
|
|
PORTUGUESE, n | 1 | 4 |
|
|
PORTUGUESE, (%) | 0.50% | 1.07% |
|
|
UNKNOWN, n | 20 | 50 |
|
|
UNKNOWN, (%) | 10.05% | 13.33% |
|
|
ASIAN, n | 8 | 12 |
|
|
ASIAN, (%) | 4.02% | 3.20% |
|
|
OTHER, n | 6 | 17 |
|
|
OTHER, (%) | 3.02% | 4.53% |
|
|
HISPANIC/LATINO, n | 8 | 17 |
|
|
HISPANIC/LATINO, (%) | 4.02% | 4.53% |
|
|
UNABLE TO OBTAIN, n | 7 | 8 |
|
|
UNABLE TO OBTAIN, (%) | 3.52% | 2.13% |
|
|
Aps III, median [Q1, Q3] | 60.00 [41.00, 85.00] | 59.00 [41.00, 84.00] | 0.517 | / |
inSOFA, median [Q1, Q3] | 1.00 [0, 4.00] | 1.00 [0, 4.00] | 0.787 | / |
▲SOFA, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [−1.00, 3.00] | 0.444 | / |
Glu_meana (mmol/L), median [Q1, Q3] | 9.43 [8.12, 11.12] | 7.15 [6.25, 8.22] | <0.001* | <0.001* |
Glu_cvb, median [Q1, Q3] | 0.30 [0.21, 0.41] | 0.21 [0.16, 0.27] | <0.001* | 0.835 |
Glu_frequency* (n/day), median [Q1, Q3] | 6.30 [4.81, 10.65] | 4.13 [2.61, 5.16] | <0.001* | <0.001* |
LOS in ICUc, median [Q1, Q3] | 4.10 [2.91, 8.82] | 5.22 [2.99, 12.77] | 0.052 | / |
LOS in hospitald, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 3.50] | 0.002 | / |
antibiotic day, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 3.50] | 0.030 | / |
infection, n | 80 | 185 | 0.030 | / |
infection, (%) | 40.20% | 49.33% | 0.043 | 0.094 |
blood-infection, n | 53 | 104 | ||
blood-infection, (%) | 26.63% | 27.73% | 0.844 | / |
Abdominal-infection, n | 18 | 57 | ||
Abdominal-infection, (%) | 9.05% | 15.20% | 0.038 | / |
urinary-infection, n | 18 | 46 | ||
urinary-infection, (%) | 9.05% | 12.27% | 0.267 | / |
respiratory-infection, n | 20 | 65 | ||
respiratory-infection, (%) | 10.05% | 17.33% | 0.019 | / |
die, n | 30 | 50 | ||
die, (%) | 15.08% | 13.33% | 0.613 | / |
hypoglycemia, n | 4 | 7 | ||
hypoglycemia, (%) | 2.86% | 3.30% | 1.000 | / |
hyperlipidemia, n | 58 | 57 | ||
hyperlipidemia, (%) | 29.15% | 15.20% | <0.001* | 0.123 |